Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Hypoglossal nerve stimulation
7 evidence topics · 5 sources
VA/DoD 2025 recommendation for referral after unsuccessful positive airway pressure therapy
FDA device criteria as summarized in the VA/DoD 2025 guideline
Procedure-related and study-related adverse events
ERS 2021 recommendation: salvage treatment rather than first-line treatment
“We suggest that HNS should not be used as first-line treatment for OSA patients in general (conditional recommendation, very low quality of evidence). However, we suggest that HNS compared to no treatment should be considered as a salvage treatment in patients with symptomatic OSA, who cannot be sufficiently treated with positive airway pressure treatment (CPAP, bilevel positive airway pressure) or MAD, and who have an AHI <50 events·h−1 and a BMI <32 kg·m−2 (conditional recommendation, very low quality of evidence) (supplementary table e13).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“There is limited evidence available for this intervention; a general recommendation was based on selected patients from three RCTs with very strict patient selection (only ∼10% of the screened patients were included) [20, 52, 53].” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
STAR trial: eligibility and twelve-month outcomes, AHI scored by a core laboratory with standard criteria
STAR trial: five-year outcomes
“From a cohort of 126 patients, 97 completed protocol, and 71 consented to a voluntary polysomnogram.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“AHI response rate (AHI <20 events per hour and >50% reduction) was 75% (n = 71). When a last observation carried forward analysis was applied, the responder rate was 63% at 5 years. Serious device-related events all related to lead/device adjustments were reported in 6% of patients.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote